Phase I, open label, tree-period crossover study of edoxaban administered through nasogastric tube in a water suspension or orally mixed in apple puree in healthy volunteers

Trial Profile

Phase I, open label, tree-period crossover study of edoxaban administered through nasogastric tube in a water suspension or orally mixed in apple puree in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Edoxaban (Primary) ; Edoxaban (Primary)
  • Indications Atrial fibrillation; Deep vein thrombosis; Embolism; Stroke; Venous thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top